Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Acquisitions (2025)

Strata Critical Medical (SRTA) has disclosed Acquisitions for 1 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Acquisitions changed N/A to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $66.5 million for FY2025, 2883.63% up from the prior year.
  • Acquisitions for Q4 2025 was $1.4 million at Strata Critical Medical.
  • The five-year high for Acquisitions was $1.4 million in Q4 2025, with the low at $1.4 million in Q4 2025.